What is CAR T Cell Therapy?

IMF Chief Medical Officer Joseph Mikhael, MD, discusses CAR T-cell therapy (chimeric antigen receptor), an approach for targeting BCMA as part of multiple myeloma treatment.
Please subscribe to our channel!
Subscribe to International Myeloma Foundation: bit.ly/XlUtPE
Visit our website at: www.myeloma.org
Find us online:
Facebook: / myeloma
Twitter: @IMFMyeloma ( / imfmyeloma )
Instagram: @imfmyeloma ( / imfmyeloma )
LinkedIn: / international-myeloma-... )
Support the IMF! bit.ly/WskQHC
Category
Nonprofits & Activism
License
Standard RUclips License